More Stories

Informist, Tuesday, Jul. 28, 2026

 

Please click here to read all liners published on this story

--Pfizer Apr-Jun net profit INR 2.04 bln
--Analysts saw Pfizer Apr-Jun net profit at INR 2.02 bln
--Pfizer Apr-Jun revenue INR 6.53 bln
--Analysts saw Pfizer Apr-Jun revenue at INR 6.45 bln
--Pfizer Apr-Jun net profit INR 2.04 bln vs INR 1.92 bln year ago
--Pfizer Apr-Jun revenue INR 6.53 bln vs INR 6.03 bln year ago

 

By Ritwika Dutta

 

MUMBAI – Pfizer Ltd. reported higher-than-expected revenue and net profit for the June quarter as the growth in the company's top line exceeded the growth in its expenses for the quarter. The company reported a net profit of INR 2.04 billion, up almost 7% on year, exceeding analysts' consensus expectations of INR 2.02 billion.

 

The company's revenue from operations rose more than 8% on year to INR 6.53 billion, also exceeding analysts' expectations of INR 6.45 billion. From the trailing quarter, the top line was up 4%. The company incurred total expenses of INR 4.21 billion during the quarter, 2.6% higher than a year ago. Purchase of stock-in-trade rose sharply by 47% from the year-ago quarter.

 

The company's finance cost, which accounts for the smallest portion of its total expenses, fell sharply by 55% on year to nearly INR 15 million in the June quarter.

 

Under expenses, the cost of materials consumed, the company's second-largest expense, rose more than 18% on year to INR 1.05 billion. Employee benefits expenses on the other hand fell 14% to INR 821 million.

 

The company's depreciation and amortisation fell 1% on year to INR 142.6 million. Other expenses were at INR 834.2 million, down almost 3% on year and 13% on quarter. The tax outgo rose more than 6% on year to INR 722.1 million.

 

Tuesday, shares of Pfizer Ltd. closed at INR 4,710.70 on the National Stock Exchange, up 0.4% from Monday. The company announced its June quarter earnings during market hours.  End

 

Edited by Rajeev Pai

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2026. All rights reserved.